Literature DB >> 23515600

Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases.

Andreu Fernández-Codina1, Fernando Martínez-Valle, Jesús Castro-Marrero, Inés Detorres, Miquel Vilardell-Tarrés, José Ordi-Ros.   

Abstract

Idiopathic retroperitoneal fibrosis (IRPF) is a rare condition of unknown aetiology characterized by chronic non-specific inflammation of the retroperitoneum. The aim of this study is to describe, for the first time, the features of Spanish patients with IRPF. In this retrospective study, a clinical description was performed to examine the histopathological features, radiologic findings, laboratory data and treatment of a cohort of 24 IRPF Spanish patients who were admitted to Vall d'Hebron Hospital in Barcelona (Spain) between 1982 and 2009. Patients with secondary retroperitoneal fibrosis were excluded. Nineteen patients (79.1 %) were male, whereas 5 were female. The mean age at diagnosis was 51.8 ± 16.4 years. Pain (79.1 %) and hydronephrosis (70.8 %) were the most common clinical manifestations. Abdominal computed tomography and ultrasonography were performed on all cases. Acute-phase reactants were elevated in most patients. Thirteen surgical biopsies were performed, and all were consistent with retroperitoneal fibrosis. Steroid therapy was given in 19 cases, and eight patients (42.1 %) required urethral catheterisation. Chronic renal failure (CRF) rate after 2 years of follow-up was 42.8 %, more frequently in patients with higher serum creatinine at diagnosis. IRPF in Spain is a rare condition affecting mainly middle-aged males, with pain and hydronephrosis as the most frequent manifestations. Steroids are the mainstay treatment, and CRF is the main sequel. An earlier diagnosis and uniform treatment protocols could prompt lower CRF rates.

Entities:  

Mesh:

Year:  2013        PMID: 23515600     DOI: 10.1007/s10067-013-2225-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Retroperitoneal fibrosis and systemic lupus erythematosus.

Authors:  H Okada; S Takahira; S Sugahara; H Nakamoto; H Suzuki
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

2.  Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases.

Authors:  Renzo Marcolongo; Ivan Matteo Tavolini; Francesco Laveder; Moira Busa; Franco Noventa; Pierfrancesco Bassi; Gianpietro Semenzato
Journal:  Am J Med       Date:  2004-02-01       Impact factor: 4.965

3.  Retroperitoneal fibrosis (Ormond's disease): clinical pathologic study of eight cases.

Authors:  Jamie Wu; Edison Catalano; Domenico Coppola
Journal:  Cancer Control       Date:  2002 Sep-Oct       Impact factor: 3.302

4.  Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone.

Authors:  Eric F H van Bommel; Claire Siemes; Liesbeth E Hak; Sacha J van der Veer; Tadek R Hendriksz
Journal:  Am J Kidney Dis       Date:  2007-05       Impact factor: 8.860

5.  Evidence of autoimmunity in chronic periaortitis: a prospective study.

Authors:  Augusto Vaglio; Domenico Corradi; Lucio Manenti; Stefania Ferretti; Giovanni Garini; Carlo Buzio
Journal:  Am J Med       Date:  2003-04-15       Impact factor: 4.965

6.  Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration.

Authors:  A H Kardar; S Kattan; E Lindstedt; K Hanash
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

Review 7.  Retroperitoneal fibrosis: report of 12 cases and a review of the literature.

Authors:  E F van Bommel; J van Spengler; B van der Hoven; P Kramer
Journal:  Neth J Med       Date:  1991-12       Impact factor: 1.422

8.  Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis.

Authors:  D V Parums; D L Brown; M J Mitchinson
Journal:  Arch Pathol Lab Med       Date:  1990-04       Impact factor: 5.534

9.  The clinical significance of retroperitoneal fibrosis.

Authors:  L Koep; G D Zuidema
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

Review 10.  Systemic extrapancreatic lesions associated with autoimmune pancreatitis.

Authors:  Hirotaka Ohara; Takahiro Nakazawa; Tomoaki Ando; Takashi Joh
Journal:  J Gastroenterol       Date:  2007-05       Impact factor: 7.527

View more
  7 in total

Review 1.  Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature.

Authors:  Hang Liu; Gejun Zhang; Yimeng Niu; Nan Jiang; Weiguo Xiao
Journal:  Rheumatol Int       Date:  2014-04-23       Impact factor: 2.631

2.  Idiopathic retroperitoneal fibrosis: IgG4 infiltration in a cohort of Spanish patients.

Authors:  Andreu Fernández-Codina; Fernando Martínez-Valle; Jesús Castro-Marrero; Inés De Torres; Miquel Vilardell-Tarrés; José Ordi-Ros
Journal:  Rheumatol Int       Date:  2014-01-10       Impact factor: 2.631

Review 3.  [New (and old) aspects of retroperitoneal fibrosis].

Authors:  A S Brandt; N M Dreger; E Müller; S Kukuk; S Roth
Journal:  Urologe A       Date:  2017-07       Impact factor: 0.639

4.  Retroperitoneal fibrosis associated with propranolol: a case report; is corticosteroid administration necessary after ureterolysis?

Authors:  Majid Shirani; Azadeh Davoudian; Abolghasem Sharifi
Journal:  J Renal Inj Prev       Date:  2013-06-01

5.  Rituximab for retroperitoneal fibrosis due to IgG4-related disease: A case report and literature review.

Authors:  Mohammad Almeqdadi; Mohammed Al-Dulaimi; Aleksandr Perepletchikov; Kevin Tomera; Bertrand L Jaber
Journal:  Clin Nephrol Case Stud       Date:  2018-04-27

6.  IgG4 related disease as a cause of isolated retroperitoneal fibrosis with no other organ involvement; Case report.

Authors:  Almurtada Razok; Rubab Malik; Priyanka Cackamvalli; Muhammad Zahid
Journal:  Ann Med Surg (Lond)       Date:  2020-12-23

7.  A Case Report of a Prevertebral Mass in an Elderly Male Post Hodgkin's Lymphoma.

Authors:  Nagapratap Ganta; Ankita Prasad; Varsha Gupta; Smriti Kochhar; Sandeep Pavuluri; Kajal Ghodasara; Pramil Cheriyath
Journal:  Cureus       Date:  2022-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.